‘Renal Disease and Transplantation Forum’ (RDTF) is the official quarterly of the Polish Nephrological Society  covering broad spectrum of topics in nephrology and transplantology, aiming to advance the knowledge and science of this systematically evolving field. It publishes peer-reviewed research papers, review articles, editorials, guidelines, short communications, case reports, quizzes and images in nephrology and transplantology, letters to the Editor and commentaries, exclusively in English language.

‘Renal Disease and Transplantation Forum’ (RDTF) publishes the following types of documents: Research Papers, Review Articles, Editorials, Guidelines, Short Communications, Case reports, Letters to the Editor, Commentaries and Short Forms (quizzes/images).

1. General rules

‘Renal Disease and Transplantology Forum’ (RDTF) intends to become an effective platform for exchanging scientific information discoveries and ideas in the field of nephrology and transplantology. To facilitate the transfer of knowledge the editorial team of RDTF kindly asks the Authors to follow the rules of preparing articles.

Authorship.

RDTF  follows and supports the rules of responsible and ethical publishing. It is understood that all persons added to the list of authors substantially participated in collecting and analysing of the data and/or in preparing the manuscript and that none of the researchers/ clinicians significantly involved in the project were neglected in the list of authors. It is also assumed that all listed Authors had read and accepted the manuscript prior to its submission.

Structure of the manuscript

Title page.

First (title) page of each manuscript should include both full and short title of the paper. Full names of the authors, academic degrees, affiliations, the name, address, phone and fax numbers as well as e-mail address of the person responsible for editorial correspondence should be given during deposition of the manuscript in the metadata table.

Title and short title

Title should be no longer than 160 characters. It should unambiguously point at the subject being considered in the paper. Short title should be of no more than 40 characters. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Abstract

Abstract is required for Research papers, Reviews, Guidelines, Case Reports and Short communications. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). The abstract should be included in the Blinded Manuscript. For letters to the Editor on previously published manuscripts, commentaries and Editorials abstracts should not be included.

Key words

The abstract or the title of the paper should be followed by up to 5 key words or phrases, in accordance with Medical Subject Headings Index Medicus if possible, allowing a precise indexing of a paper. The exact name of clinical entity being the main topic of the paper should be mentioned as one of the key words. Please, avoid general and plural terms as well as abbreviations.

Ethical permission

A statement on ethical approval of every submitted paper describing clinical observations or experiments should be included in the methodological part of the manuscript.

Illustrations

Illustrations should be submitted as separate files with captions provided within the text of the manuscript. The illustrations should be numbered accordingly to the order of appearance in the text and sent as JPG, TIFF files (with the number of a figure indicated in the name of the file). Previously printed visual materials should be supplied together with the written consent of the publisher for republication.

Tables

Tables should be prepared with the same text processing software as the rest of the manuscript. The tables should be numbered consecutively as they appear in the text. Tables should be placed on separate pages at the end of the manuscript.

Units of measure

Laboratory values should be expressed using the International System of Units (Le Système International d’Unités, SI) in lower-case letters (e.g. mmol/l), with the exception of blood pressure values which are to be reported in mm Hg. Temperatures are to be given in degrees Celsius. If conventional units are used, their SI equivalents should be provided in parentheses only at first mention in the text. In tables, conversion factors should be provided at footnotes according to the following example: “SI conversion factors: to convert C-reactive protein to nmol/l, multiply by 9.524; glucose to mmol/l, by 0.0555; ...”

References

The Vancouver style of referencing is required in papers submitted to RDTF. The number of references for specific types of articles should be limited as follows: Research papers: up to 40, Review articles: up to 100, Editorials: up to 30, Guidelines: no limits, Short communications: up to 15, Clinical Vignettes and Short Forms: up to 5, Letters to the Editor and Commentaries: up to 10. Additional references however, can be placed in supplementary material.

Funding

Detailed information on the funding source should be given after the main text of the manuscript. When no external sources of funding were involved in the process of preparation of the manuscript it should be stated as follows: ‘This publication was prepared without any external sources of funding’.

Conflict of interest

Any possible conflict of interest regarding the topic of the submitted paper should be mentioned for all the authors in a separate paragraph following the main text of the manuscript. 

Brief requirements for articles are now summarized in the following table. For each type of manuscript more detailed instructions regarding its structure are presented below.

1. Research papers.

Research papers presenting results of performed experiments and/or clinical observations are the essential type of publications in RDTF.

1. Word Count.

Research papers should contain no more than 3000 words, excluding references, Illustrations' captions and Tables.

2. Title.

Title should be informative and concise, if possible, directly addressing clinical entity or problem described in the manuscript, no longer than 160 characters.

3. Abstract.

Abstract should be no longer than 250 words. It should be divided into following paragraphs: should consist of four distinct paragraphs: Background and Aim of the Study, Materials and Methods, Results and Conclusions.

4. Key words.

The abstract should be followed by up to 5 key words. At least one of the key words should be a name of specific clinical entity (e.g. Renal cancer), syndrome (e.g. Renal insufficiency) or procedure (e.g. urography).

5. Structure and content of the main text.

The main text should be divided into following sections:

Introduction, defining the topic of the paper and putting it in context of recent publications; 

Clinical Rationale for the Study - a short paragraph explaining why results of the study are supposed to be clinically useful or scientifically inspiring; 

Materials and Methods, a description of studied and control populations and performed intervention or undertaken observation. It should also contain precise description of laboratory experiments (where applicable) allowing its reproduction and of statistical methods used for analysis of the data. The Authors should also add their statement upon ethical approval of their project to this section. 

Results, report the findings of the study based upon the information gathered as an outcome of the methodology applied. This section should simply state the findings, without bias or interpretation and be arranged in a logical sequence.

Discussion and Conclusions, the Authors are kindly asked to put their findings in the context of the recent publications in the field. The Discussion should also point at strong and weak aspects of the described study. The limitations of the work should be also included. The Authors are obliged to sum up their discussion with specific conclusions coming from confrontation of their findings with data found in the literature. 

Clinical Implications/Future Directions - short paragraph of 5 - 8 sentences, explaining if/how results of this study may influence everyday clinical practice and what further scientific efforts should be undertaken to add new data to the field.

6. Number of Tables and Illustrations.

Research papers may contain together up to 8 Tables and/or Illustrations numbered accordingly to their appearance in the text, titled and described in a way allowing unambiguous placing them within the text. Additional Tables and/or Illustrations (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. P value.

When any P value is expressed, it should be clear to the reader what parameters and groups were compared, what statistical test was performed, and whether the test was 1-tailed or 2-tailed (if relevant). For P values, the actual value for P should be expressed to 2 digits for P ≥0.01, whether or not P is significant. However, when rounding a P value expressed to 3 digits would make the P value nonsignificant (such as P >0.049 rounded to 0.05), the P value can be left as 3 digits. If P <0.01, it should be expressed to 3 digits. The actual P value should be expressed (P = 0.04), rather than expressing a statement of inequality (P <0.05), unless P

8. References.

Research papers should have no more than 40 references.

III. Review articles

It is not obligatory but authors are encouraged to propose topics and titles of reviews to be published in RDTF. Author(s) proposing a review is kindly asked to present to the Editor in Chief a preliminary abstract of the paper (up to 250 words) to assess if the merit of the article is within the scope of RDTF or there are no similar reviews under consideration. Editor-in-Chief decides whether to commission a full review from the Author(s).

1. Word count.

Review article should contain no more than 6000 words, excluding references, Illustrations' captions and Tables

2. Title.

Informative and highly specific titles are preferred.

3. Abstract.

An abstract of no more than 250 words is required. The abstract, unstructured should shortly define topics covered by the Review and signal whether the paper is addressed more to clinicians or to researchers.

4. Key words.

The abstract should be followed by up to 5 key words. At least one of the key words should be a name of specific clinical entity (e.g. Bronchial asthma), syndrome (e.g. Dyspnoea) or procedure (e.g. Bronchoscopy).

5. Structure and content of the main text.

Although the structure of Review should rather serve the Authors to present their ideas, nevertheless a following organization of the text is suggested:

Introduction defining the area of Review and purposes of the Review. State of the Art section describing significance of the topic of Review, presenting actual knowledge in the field with special consideration given to discoveries published most recently. Clinical Implications panel summing up the most important facts presented in the Review that may increase clinical effectiveness and help to avoid mistakes. Future Directions panel summing up unanswered questions in the field and formulating challenges for researchers.

6. Number of Tables And Illustrations.

Reviews may contain together up to 6 Tables and/or Illustrations. Additional figures (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References.

Reviews may contain up to 100 references.

1. Guidelines

RDTF is open for proposals of publishing papers containing clinical guidelines prepared by medical societies and other clinical and scientific groups of experts. Guideline papers should fulfil specific criteria described below:

1. Word count.

Guideline should contain no more than 8000 words, excluding references, Illustrations' captions and Tables.

2. Title.

The Title should contain the names(s) of the organization(s) preparing the guidelines and the specific clinical condition to which the guideline applies.

3. Abstract.

Abstract should contain no more than 250 words. It should shortly describe the clinical condition being the subject of the guidelines and present most important guidelines. Abstract should be divided into following paragraphs: Introduction, Aim of the Guideline, Results, and Conclusions.

4. Key words.

Abstract should be followed by up to 5 key words.

5. Structure and content of the main text should be organized according to recommendations upon which authors based their manuscript. The source of such recommendation should be provided.
6. Number of Tables And Illustrations.

Guideline may contain together up to 16 Tables and/or Illustrations . Additional Tables and/or Illustrations (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References.

Number of references in Guideline should be rational but the decision is left with the Authors.

1. Short Communications

Short communication is a type of article serving for presentation of data coming from case series, short projects of preliminary studies.

1. Word count.

Short communications should contain no more than 1500 words, excluding references, Illustrations, captions and Tables.

2. Title.

Title should be informative and concise, preferably directly addressing clinical entity or problem described in the manuscript, no longer than 160 characters.

3. Abstract.

Abstract should be no longer than 250 words. It should be divided into following paragraphs: Aim of the study; Materials and Methods; Results; Conclusions and Clinical Implications.

4. Key words.

The abstract should be followed by up to 5 key words. At least one of the key words should be a name of specific clinical entity (e.g. Bronchial asthma), syndrome (e.g. Dyspnoea) or procedure (e.g. Bronchoscopy).

5. Structure and content of the main text.

The main text should be divided into following sections:

Introduction. Very short paragraph defining the topic of the paper and putting it in context of recent publications; Materials and Methods- a description of studied and control populations and performed intervention or undertaken observation. It should also contain precise description of laboratory experiments (where applicable) allowing its reproduction and of statistical methods used for analysis of the data. The Authors should also add their statement upon ethical approval of their project to this section. Discussion. The Authors are kindly asked to put their specific findings in the context of the most recent publications in the field. The Authors are obliged to sum up their discussion with specific conclusions resulting from confrontation of their findings with data found in the literature.  Clinical Implications/Future Directions - short (but crucial for Short communications) paragraph of 3 - 4 sentences, explaining if/how results of this study may influence everyday clinical practice and what further scientific efforts should be undertaken to add new data to the field.

6. Number of Tables And Illustrations.

Short communications may only contain together up to 2 Tables and/or Illustrations. Additional figures (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References.

Short communications may contain up to 15 references.

1. Case Reports

Classical case reports will be published occasionally, under condition that they have unique clinical and/or scientific significance. It is advisable to contact RDTF editorial office before such submission is planned.  

1. Word count.

Case Reports should contain no more than 2000 words, including title, abstract, references, and figure legends.

2. Title.

Title should be informative enough to give the reader the most important information presented.

3. Abstract.

Unstructured, of no more than 250 words.

4. Key words.

The title should be followed by up to 5 key words.

5. Structure and content of the main text.

No specific structure is required.

6. Number of Illustrations / Tables.

Case Reports may contain together up to 6 Tables and/or Illustrations. Additional figures (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References.

Case Reports may contain up to 15 references.

VII. Editorials

Editorials are articles written by the Editors of RDTF or by Authors invited by the Editors. Typically, the aim of Editorial is to comment a paper published in RDTF or to place it in a wider scientific context.

1. Word count.

Editorial should contain no more than 2000 words, excluding references.

2. Title.

Title should be relevant to the article commented.

3. Abstract.

Abstract is not required.

4. Key words.

Key words are not required for Editorials.

5. Structure and content of the main text.

Editorials are not supposed to be specifically structured.

6. Number of Tables And Illustrations.

Editorials may contain together up to 2 Tables and/or Illustrations. Additional figures (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References.

Editorials may contain up to 30 references.

VIII. Short forms (quiz / image)

Short forms should be prepared according to guides provided in the Table above.

1. Letters to the Editor

Authors are invited to submit their clinical observations in form of Letters to the Editor.

1. Word count.

Letter to the Editor should contain no more than 1000 words, excluding references, Illustrations' captions and Tables.

2. Title.

Title should be informative enough to give the reader the most important information presented in the Letter to the Editor.

3. Abstract.

No abstract is required.

4. Key words.

The title should be followed by up to 5 key words.

5. Structure and content of the main text.

Although no specific structure is required, the Authors are asked to present the clinical observation first, then to place it in context of published data with special attention given to novelty and uniqueness of the presented finding.

6. Number of Tables And Illustrations.

Letters to the Editor may contain together up to 2 tables and/or Illustrations.  Additional figures (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References.

Letters to the Editor may contain up to 10 references.

1. Commentaries

As creative discussion is sine qua non for development of science the Editors invite the readers of RDTF to submit their reflexions or doubts provoked by papers published in the journal. Submissions related to research papers are of special value. Those articles will be published as Commentaries. If only possible they will be answered by the Authors of original contribution.

1. Word count.

Commentaries should contain no more than 1000 words, excluding references, Illustrations' captions and Tables.

2. Title.

Title should refer directly to the paper that provoked the Comment

3. Abstract.

No abstract is required.

4. Key words.

No key words are required.

5. Structure and content of the main text.

Although no specific structure is required, the Authors are asked to present shortly the research paper and then to express their reflexions supported by previously published data.

6. Number of Tables.

Commentaries may contain a single Table. Additional Tables (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. Number of Illustrations.

Commentaries may also contain a single Illustrations. Additional Illustrations (clearly addressed in the text of manuscript) may be submitted as supplementary material.

7. References. Commentaries may contain up to 10 references.

Please, see also section: ‘Types Of Article’ to read the details on the exact type of article you wish to submit. 

Double-blind review

To facilitate double-blind review, please make sure that main body of the paper (including title page, references, figures, tables and any acknowledgements) do not include any identifying information, such as the authors' names or affiliations.

Use of word processing software

File should be saved in the native format of the word processor used. The text should be in single-column format with the layout of the text as simple as possible. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. To avoid unnecessary errors, please use the 'spell-check' and 'grammar-check' functions of your word processor.

Article structure – additional information

Subdivision - numbered sections.

Divide your article into clearly defined and numbered sections. Subsections should be also be numbered  but  abstract should not be included in section numbering. Any subsection may be given a brief heading. Each heading should appear on its own separate line.

Acknowledgements

Collate acknowledgements in a separate section and include it on the title page only. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).

Abbreviations

Abbreviations that are unavoidable must be defined twice: (1) at their first mention in the Abstract and (2) at their first mention in the remaining part of the article. Ensure consistency of abbreviations throughout the article.

Units

Please, use the international system of units (SI). If other units are mentioned, please give their equivalent in SI.

Footnotes

Footnotes should be used sparingly. Number them consecutively throughout the article. Many word processors can build footnotes into the text, and this feature may be used. Otherwise, please indicate the position of footnotes in the text and list the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.

Electronic artwork

General remarks

• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.

Formats

If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format. Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats:

EPS (or PDF): Vector drawings, embed all used fonts. TIFF (or JPEG): Colour or grayscale photographs (halftones), keep to a minimum of 300 dpi. TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi. TIFF (or JPEG): Combinations bitmapped line/halftone (colour or grayscale), keep to a minimum of 500 dpi.

Please, do not:

• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colours;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.

Figure captions

Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.

Tables

Please submit tables as editable text and not as images. When preparing tables, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules and shading in table cells.

References — should be numbered consecutively according to their appearance in the text (not the alphabetical order). Numbered references to personal communication, unpublished data, and manuscripts either ″in preparation″ or ″submitted for publication″ are not recommended. If essential, such material may be incorporated in the appropriate place in the text. Examples:
Journals
Miller KR, McClave SA, Kirrily LN, et al. A tutorial on enteral access in adult patients in the hospitalized setting. JPEN J Parenter Enteral Nutr. 2014; 38(3): 282–295.

Books
The consecutive reference number, author, title, the editor, the place and the year of publication should be given. Reference to the specific chapter should include: name of the author and his initials, chapter title, pages, name of the author (editor) of the book and his initials, the editor, year and place of publication.
Example (author and editor are different): Fernandes LB, Henry PJ, Goldie RG. Pharmacology and Therapeutics of Asthma and COPD. Page CP, Barnes PJ (ed.)., Springer, Heidelberg 2004; 20–31.
Example (author is the editor): Morice AH, Bush A. Cough. Current Medical Literature Ltd, London 2003; 34–38.

Reference links

Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. Use of the DOI link is highly encouraged as it is guaranteed never to change. Please note the format of such citations should be in the same style as all other references in the paper.

Web references

As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given.

Supplementary material

Supplementary material such as applications, images and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received. Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version.

Publication mode

This Journal has adopted a gold open access to all articles.  There is no charge for publication in ‘Renal Disease and Transplantation Forum’.

Ethics

Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at http://www.icmje.org/recommendations/). 

Via Medica recommends journal Editors, Authors and Readers to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information please visit the COPE website: http://publicationethics.org/.

Human and animal participants and clinical trials. All research involving ′human and animal participants and clinical trials′ must have the authors institutional review board/local ethical committee approval. Authors are required to include in the Methods section a brief statement identifying the committee approving the experiments. All experiments involving humans must have been conducted according to the principles stated in the Declaration of Helsinki. Authors are obliged to include a declaration confirming that informed consent was obtained from all participants. For animal experimentation reported in the Journal, it is expected that investigators will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing and Education issued by the New York Academy of Sciences Ad Hoc Committee on Animal Research. Adherence to these principles should be indicated in the text of manuscript.

It is also a responsibility of the author to secure patients personal data. Such critical data as name, surname, date of birth or any other that may enable the identification of a subject MUST be deleted from the text, patients results or other files provided.

Authorship 

All collaborators who have made significant and substantial contributions to a study are considered co-authors. The nature and level of contribution of all authors of accepted manuscripts must be indicated, i.e. conception, design, execution and interpretation of the data being published, wrote the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Other contributions to the work, such as providing of reagents or analytic tools, should be listed in the Acknowledgements. Ghost-writing and guest-authorship are forbidden. In case of detecting ghost written manuscripts, actions will be taken involving both the submitting authors and the participants involved.

Articles should be free of fabrication, falsification and plagiarism (more information at: ori.hhs.gov/misconduct/definition_misconduct.shtml).

The corresponding author must have obtained permission from all authors for the submission of each version of the paper and for any change in authorship. Submission of a paper that has not been approved by all authors may result in immediate rejection. To secure release from the responsibilities to the third parties, corresponding author is required to return to the Publisher a singed copy of the <Authors' Statement> together with the manuscript. Authors'  Statement form is available through the link at the end of Submissions section. All authors must agree to the conditions of publication, however the final responsibility for this information lays on the author submitting the manuscript.

Conflict of interest

To meet the responsibility to the public to provide clear and unbiased scientific information, all authors must disclose any association that poses a conflict of interest in connection with the manuscript. Authors must indicate any affiliations, funding sources, or financial holdings that might raise questions about possible causes of bias. This information will not be revealed to the reviewers and will not influence the decision concerning the acceptance of the manuscript. After the article is accepted for publication the Editor will discuss with the authors the manner in which the information concerning the financial sources should be provided to the readers. Reviewers and editors are also required to report any conflict of interest in case of recent collaborations with the author (co-authored a paper or worked together on a grant with the author within the past 24 months). Other examples of possible conflicts include a close personal friendship, past or present association as thesis advisor or thesis student, or a family relationship. Additionally, in case of articles presenting drugs or medical equipment, reviewers and editors should disclose to the Editor-in-Chief any financial relations with the corporations manufacturing described drugs and/or equipment.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout.

Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Language (usage and editing services)

Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English should use the recognized English Language Editing services involved in medical writing.   

Permissions

Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to ‘Renal Disease and Transplantation Forum’ for reproduction. Obtain permission in writing from at least one author of papers still in press, unpublished data, and personal communications. Figures or tables that have been published elsewhere must be identified, and written permission of the original copyright owner must be provided. Such responsibility lies entirely with the authors and the Publisher will not be liable for violation of anyone’s copyright or other rights by the authors.

Already have a Username/Password for Renal Disease and Transplantation Forum?

Registration and login are required to submit items online and to check the status of current submissions.

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Completion of the online submission form electronically is tantamount to automatically and free-of-charge transferring of the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploitation) to the Journal Owner, under condition that those materials are accepted for publication. The authors agree not to publish any data or figures presented in their work anywhere and in any language without the prior written consent of the copyright holder or party acting on its behalf.  Legal relations between the copyright holder and the author(s) are in accordance with Polish law and with international conventions binding to Poland. The legal bases to acquiring the copyright are article 921 section copyright law and related law as well as the international conventions binding to Poland.

This Journal is published four times yearly, no later than last day of each quarter of calendar year.